Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1375231

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1375231

Antiparasitic Drugs Market by Drug Type (Anthelmintics, Antiprotozoals, Ectoparasiticides), Form (Injections, Oral Tablets/Capsules, Topical Creams), Indication, Distribution Channel, End-User - Global Forecast 2023-2030

PUBLISHED:
PAGES: 198 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

The Antiparasitic Drugs Market is projected to reach USD 27.94 billion by 2030 from USD 19.63 billion in 2022, at a CAGR of 4.50% during the forecast period.

Global Antiparasitic Drugs Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 19.63 billion
Estimated Year Value [2023] USD 20.40 billion
Forecast Year Value [2030] USD 27.94 billion
CAGR (%) 4.50%
Antiparasitic Drugs Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Antiparasitic Drugs Market.

Based on Drug Type, market is studied across Anthelmintics, Antiprotozoals, Ectoparasiticides, and Endoparaciticides. The Endoparaciticides is projected to witness significant market share during forecast period.

Based on Form, market is studied across Injections, Oral Tablets/Capsules, and Topical Creams. The Oral Tablets/Capsules is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Fleas, Intestinal Parasites, Lice, Malaria, Scabies, and Ticks. The Fleas is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Offline and Online. The Online is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Home Care Facilities, Hospitals & Clinics, and Veterinary Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Antiparasitic Drugs Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Antiparasitic Drugs Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Antiparasitic Drugs Market, highlighting leading vendors and their innovative profiles. These include Adva Care Pharma, Algen Healthcare Ltd., Amneal Pharmaceuticals LLC, Bayer AG, Ben Pharmaceuticals, Centurion Laboratories Private Limited, Cipla Ltd., Consern Pharma Limited, Dr.Reddys Laboratories Inc., F. Hoffmann-La Roche AG, Fredun Group, Garcia Life Sciences, Glaxosmithkline PLC, Healthy Life Pharma Private Limited, Ipca Laboratories, Jackson Laboratories Pvt Ltd., Mankind Pharma, Merck KgaA, Novartis AG, Sanofi, Soigner Pharma by Arlak Biotech, Sriwalls Health Care, Taj Life Sciences Pvt. Ltd., Weefsel Pharma, and Zydus Group.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Antiparasitic Drugs Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Antiparasitic Drugs Market?

3. What is the competitive strategic window for identifying opportunities in the Antiparasitic Drugs Market?

4. What are the latest technology trends and regulatory frameworks in the Antiparasitic Drugs Market?

5. What is the market share of the leading vendors in the Antiparasitic Drugs Market?

6. Which modes and strategic moves are suitable for entering the Antiparasitic Drugs Market?

Product Code: MRR-B1685377777A

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antiparasitic Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence and awareness of parasite infection across the globe
      • 5.1.1.2. Favorable government initiatives for parasite infection management
      • 5.1.1.3. Increasing investment in research and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Requirement of huge capital for drug development
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals for antiparasitic drugs from several regulatory authorities
      • 5.1.3.2. Introduction of novel antiparasitic drugs by manufacturers
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects and risks associated with the drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antiparasitic Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Anthelmintics
  • 6.3. Antiprotozoals
  • 6.4. Ectoparasiticides
  • 6.5. Endoparaciticides

7. Antiparasitic Drugs Market, by Form

  • 7.1. Introduction
  • 7.2. Injections
  • 7.3. Oral Tablets/Capsules
  • 7.4. Topical Creams

8. Antiparasitic Drugs Market, by Indication

  • 8.1. Introduction
  • 8.2. Fleas
  • 8.3. Intestinal Parasites
  • 8.4. Lice
  • 8.5. Malaria
  • 8.6. Scabies
  • 8.7. Ticks

9. Antiparasitic Drugs Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Antiparasitic Drugs Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Care Facilities
  • 10.3. Hospitals & Clinics
  • 10.4. Veterinary Clinics

11. Americas Antiparasitic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Antiparasitic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Antiparasitic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Adva Care Pharma
    • 15.1.2. Algen Healthcare Ltd.
    • 15.1.3. Amneal Pharmaceuticals LLC
    • 15.1.4. Bayer AG
    • 15.1.5. Ben Pharmaceuticals
    • 15.1.6. Centurion Laboratories Private Limited
    • 15.1.7. Cipla Ltd.
    • 15.1.8. Consern Pharma Limited
    • 15.1.9. Dr.Reddys Laboratories Inc.
    • 15.1.10. F. Hoffmann-La Roche AG
    • 15.1.11. Fredun Group
    • 15.1.12. Garcia Life Sciences
    • 15.1.13. Glaxosmithkline PLC
    • 15.1.14. Healthy Life Pharma Private Limited
    • 15.1.15. Ipca Laboratories
    • 15.1.16. Jackson Laboratories Pvt Ltd.
    • 15.1.17. Mankind Pharma
    • 15.1.18. Merck KgaA
    • 15.1.19. Novartis AG
    • 15.1.20. Sanofi
    • 15.1.21. Soigner Pharma by Arlak Biotech
    • 15.1.22. Sriwalls Health Care
    • 15.1.23. Taj Life Sciences Pvt. Ltd.
    • 15.1.24. Weefsel Pharma
    • 15.1.25. Zydus Group
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing
Product Code: MRR-B1685377777A

LIST OF FIGURES

  • FIGURE 1. ANTIPARASITIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIPARASITIC DRUGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. ANTIPARASITIC DRUGS MARKET DYNAMICS
  • FIGURE 7. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 8. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2022 VS 2030 (%)
  • FIGURE 10. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 12. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 14. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 16. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 25. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 26. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ANTIPARASITIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ANTIPARASITIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIPARASITIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIPARASITIC DRUGS MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIPARASITIC DRUGS MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIPARASITIC DRUGS MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIPARASITIC DRUGS MARKET SIZE, BY ENDOPARACITICIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIPARASITIC DRUGS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIPARASITIC DRUGS MARKET SIZE, BY ORAL TABLETS/CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIPARASITIC DRUGS MARKET SIZE, BY TOPICAL CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIPARASITIC DRUGS MARKET SIZE, BY FLEAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIPARASITIC DRUGS MARKET SIZE, BY INTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIPARASITIC DRUGS MARKET SIZE, BY LICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIPARASITIC DRUGS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIPARASITIC DRUGS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIPARASITIC DRUGS MARKET SIZE, BY TICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. ANTIPARASITIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANTIPARASITIC DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. ANTIPARASITIC DRUGS MARKET SIZE, BY HOME CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANTIPARASITIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ANTIPARASITIC DRUGS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ANTIPARASITIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM ANTIPARASITIC DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. ANTIPARASITIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 238. ANTIPARASITIC DRUGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 239. ANTIPARASITIC DRUGS MARKET LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!